Gen AI and large language models (LLMs) are transforming how patients research symptoms, treatments, and side effects—often in places pharma cannot see or measure. While social channels remain visible, private LLM chats and closed messaging apps create blind spots for safety, compliance, and commercial teams as adverse events, off-label use, and misinformation increasingly surface there first.

This webinar will use Resolver’s analyst-led risk insights to show how Gen AI is reshaping risk in pharma, and provide a pragmatic playbook for monitoring, governing, and responding to LLM-driven risks while still enabling innovative, AI-powered engagement aligned with Future Pharma’s focus on trust, access, and execution.

Key Takeaways:

• ◎ How Gen AI and LLMs are changing patient behavior and decision-making in ways traditional listening often misses.
• ◎ Where “dark” LLM and private-channel risks emerge, including hidden safety signals, off-label chatter, and misinformation.
• ◎ How analyst-led risk intelligence can surface and contextualize Gen AI–driven risk patterns at the company or brand level.
• ◎ Practical guardrails for using Gen AI in marketing and MLR that balance innovation with regulatory and reputational risk.
• ◎ A simple cross-functional framework for commercial, digital, and safety teams to monitor and respond to Gen AI–related risks.

Don’t miss out! Register now to watch the entire on-demand webinar.

Available On-Demand Now!